• Print
  • Share
close

Share this on...

Share this site with others using one of these sharing tools.

 

Link to this article

To link to this article, paste this block of HTML code onto your webpage.

Guidelines for sites linking to mayoclinic.org

Guillain-Barre Syndrome

Overview

Guillain-Barre syndrome (GBS), also known as acute inflammatory demyelinating polyradiculoneuropathy (AIDP), is a disorder in which your immune system attacks your nervous system. The syndrome often appears following a cold or flu, sore throat or recent immunization. Symptoms usually begin with tingling and muscle weakness in your feet or legs, which can spread to your upper body and arms. In serious cases, you may become nearly paralyzed within a few days or weeks, and the weakness can involve the muscles that control breathing.

Although most people who have GBS recover completely, some people may have serious, lifelong disabilities or conditions. Because Guillain-Barre syndrome progresses so rapidly and can be life threatening, early medical treatment is important. Your doctor treats your condition by prescribing medications that suppress the autoimmune attack on nerves and stabilizing your health, as well as providing mechanical ventilation if needed. Your treatment team also will provide rehabilitation throughout your care. Guillain-Barre syndrome is relatively rare, affecting 1 or 2 of 100,000 people per year.

Why choose Mayo Clinic

At Mayo Clinic, a team of doctors trained in neurology, physical medicine and rehabilitation, intensive care medicine and other areas work together closely to care for people who have Guillain-Barre syndrome.

Mayo Clinic in Rochester, Minn., is ranked among the Best Hospitals for neurology and neurosurgery by U.S. News & World Report.

Read more about Guillain-Barre Syndrome at MayoClinic.com.

Request Appointment
  • Arizona
  • Florida
  • Minnesota
  • Print

Find Mayo Clinic on


Terms of Use and Information Applicable to this Site
Copyright ©2001-2012 Mayo Foundation for Medical Education and Research. All Rights Reserved.

.